PARSE BIOSCIENCES, INC.

Parse Biosciences, Inc. specializes in advanced single-cell genomics and high-throughput biological research solutions, delivering cutting-edge reagents, instrumentation, and automation platforms for spatial transcriptomics and nucleic acid sequencing. Their core capabilities center on developing and manufacturing reagent kits for single-cell RNA and TCR sequencing, alongside integrated laboratory automation bundles that enable scalable analysis of up to 100,000 cells or nuclei per experiment. The company excels in end-to-end protocol design for complex biological samples, with demonstrated expertise in UDI-compliant plate workflows, sequencing reagent formulation, and instrument integration for analytical laboratories. Their technical differentiation lies in precision-targeted molecular tools optimized for low-input, high-resolution single-cell applications, supporting both basic research and translational immunology studies. Parse Biosciences maintains a strong, consistent relationship with the Department of Health and Human Services, providing critical research tools and biological reagents for advanced genomic investigations, including studies on rare immune disorders such as hemophagocytic lymphohistiocytosis. Their work with HHS spans R&D, reagent manufacturing, and instrument delivery, reflecting a trusted partnership in supporting federal biomedical innovation. They also serve the Environmental Protection Agency with technology adjustments and protocol enhancements for environmental genomics applications. The company’s primary industry focus is in biotechnology research and development (NAICS 541714), with complementary capabilities in biological product manufacturing (325414) and analytical instrument production (334516). This positions them as a niche provider at the intersection of molecular biology, automation, and next-generation sequencing infrastructure, serving government-funded life sciences and public health initiatives. Parse Biosciences, Inc. is a small business headquartered in Seattle, Washington, with no federal certifications on record. Their geographic presence is centered in the Pacific Northwest’s biotech corridor, leveraging regional expertise in life sciences innovation to support federal R&D priorities.